Gilead Sciences, Inc. · NASDAQ:GILD

Dickinson Andrew D sold 3,000 Gilead Sciences, Inc. shares (Form 4)

Traded Nov 16, 2026 · Filed Nov 17, 2026

On Nov 16, 2026, Dickinson Andrew D (Chief Financial Officer) sold 3,000 Gilead Sciences, Inc. shares at US$171.47 for US$514K under a trading plan, leaving 158,096 shares. Filed Nov 17, 2026 (Form 4).

Sold
3,000 shares
Price
US$171.47
Value
US$514K
Holding after
158,096 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 16, 2026Common StockSale3,000US$171.47158,096Direct

Source

Download original · View original at SEC

Related